InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Solomons Neil, Directeur Médical. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 6 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €2m. Activity tracked since 9 August 2021. The latest transaction was filed on 2 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Solomons Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
8,500 shares0Common StockSEC:0001628280-22-005119:0
50,000 shares@ US$30.1750.1% of flowCommon SharesSEC:0001628280-21-023153:0
45,000 shares@ US$5.307.9% of flowCommon StockSEC:0001628280-21-021484:0
150,000 shares@ US$3.2015.7% of flowCommon SharesSEC:0001628280-21-018594:0
5,000 shares@ US$15.852.6% of flowCommon StockSEC:0001628280-21-017662:0
45,000 shares@ US$16.0323.7% of flowCommon StockSEC:0001628280-21-016407:0
6 of 6 declarations
About Solomons Neil
Neil Solomons is the Chief Medical Officer at Aurinia Pharmaceuticals Inc. He oversees the company's clinical and research initiatives, ensuring innovation in the field of pharmaceuticals. His medical expertise is essential for the development of new therapies.
